You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 15, 2024

MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Milrinone Lactate In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Milrinone Lactate In Dextrose 5% In Plastic Container is a drug marketed by B Braun, Baxter Hlthcare, Gland Pharma Ltd, Hikma, Hospira, West-ward Pharms Int, and Woodward. and is included in eight NDAs.

The generic ingredient in MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Milrinone Lactate In Dextrose 5% In Plastic Container

A generic version of MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as milrinone lactate by FRESENIUS KABI USA on May 28th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What are the global sales for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Children's Medical CenterPhase 3
Ottawa Heart Institute Research CorporationPhase 4
Thrasher Research FundN/A

See all MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

Pharmacology for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 076414-001 Aug 18, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 075510-001 May 28, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 075834-002 May 28, 2002 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Woodward MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 077151-001 Jul 20, 2005 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.